TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/20/08 16:45 | 3/19/08 | OMRI | Omrix Biopharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Taub Robert | NY | DO | CEO | P.m | 979 | 12.24 | 0 | 80 | 3 | 2,797 | I | ||||||||||||||
1/18/07 14:36 | 1/17/07 | OMRI | Omrix Biopharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Taub Robert | NY | DO | P,CEO | S | -3,080 | 30.08 | 0 | -102 | -8 | 1,210 | I | ||||||||||||||
12/20/06 12:35 | 12/20/06 | OMRI | Omrix Biopharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Taub Robert | NY | DO | P,CEO | S.d | -20,533 | 30.08 | 0 | -683 | -19 | 2,847 | M |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |